Results 171 to 180 of about 12,412 (210)

Hidradenitis Suppurativa and IL-17 Inhibitors: A Focus on Trials and Real-Life Data. [PDF]

Medicina (Kaunas)
Martora F, Tommasino N, Esposito V, Brescia C, Megna M.   +4 more
europepmc   +1 more source

No major effect of age (< 40 vs. ≥ 40 years) on response to secukinumab in patients with axSpA: a post hoc analysis of six phase 3 trials. [PDF]

Arthritis Res Ther
Ramiro S, Gaillez C, Kiltz U, Gensler LS, Pisal C, Braun J, Ogdie A.   +6 more
europepmc   +1 more source

Retention, Effectiveness, and Safety of Secukinumab in Plaque Psoriasis: 5-Year Results from SERENA. [PDF]

Dermatol Ther (Heidelb)
Augustin M, Sator PG, von Kiedrowski R, Rigopoulos D, Romanelli M, Ghislain PD, Torres T, Ioannides D, Vizcaya C, Clemens A, Bao W, Pieterse CC, Schulz B, Jagiello P, Conrad C.   +14 more
europepmc   +1 more source

Marked improvement of isolated acrodermatitis continua of hallopeau with upadacitinib: a case report and literature review. [PDF]

Front Med (Lausanne)
Li M, Zhang GX, Wu YL, Huang HY.
europepmc   +1 more source

Efficacy and Safety of Xeligekimab Compared to Other IL-17A Inhibitors for Chinese Patients with Moderate-to-severe Plaque Psoriasis: A Matching-adjusted Indirect Comparisons. [PDF]

Acta Derm Venereol
Ding Y, Liu W.
europepmc   +1 more source

Ixekizumab-induced cutaneous vasculitis: A rare challenge in the era of biologic therapies. [PDF]

JAAD Case Rep
Benavides Tulcán EY, Vanegas Arciniegas SI, Lozano Ponce EA.   +2 more
europepmc   +1 more source

IL-17 Signaling Inhibitors in Localized Scleroderma: A Single-Center Case Series of Nine Patients. [PDF]

J Dermatol
Takahashi T, Takahashi T, Segawa Y, Oka K, Takahashi T, Asano Y.   +5 more
europepmc   +1 more source

A Narrative Review of Secukinumab in Spondyloarthritis and Psoriatic Arthritis: Treating the Whole Patient. [PDF]

Rheumatol Ther
Kaeley GS, Kivitz A, Mease P, Weiss PF, Grinnell-Merrick L, Gladman DD.   +5 more
europepmc   +1 more source

Systemic inflammatory response drives post-cardiac arrest multi-organ injury via IL-17 signaling in murine and porcine models. [PDF]

Front Immunol
Yan Y, Chen T, Yuan A, Geng N, Wan F, Fang P, Qiao Z, Wei Z, Pu J.   +8 more
europepmc   +1 more source

Markedly improved disease control in Darier disease (<i>ATP2A2</i>-nonsyndromic epidermal differentiation disorder) with ustekinumab versus other biologics: a case series. [PDF]

Skin Health Dis
Skarnvad Andersen A, Baez E, Emmanuel T, Rønholt K, Sommerlund M, Johansen C.   +5 more
europepmc   +1 more source